RIL
IMVT icon

Rothschild Investment LLC’s Immunovant IMVT Stock Holding History

Rothschild Investment LLC’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.24K Buy
110
+1
+0.9% +$30 ﹤0.01% 2384
2026
Q1 		$2.71K Buy
109
+23
+27% +$595 ﹤0.01% 2400
2025
Q4 		$2.19K Buy
86
+31
+56% +$691 ﹤0.01% 2320
2025
Q3 		$887 Sell
55
-105
-66% -$1.7K ﹤0.01% 2637
2025
Q2 		$2.56K Buy
160
+110
+220% +$1.66K ﹤0.01% 1893
2025
Q1 		$855 Sell
50
-5
-9% -$105 ﹤0.01% 2422
2024
Q4 		$1.36K Sell
55
-5
-8% -$142 ﹤0.01% 2035
2024
Q3 		$1.71K Buy
60
+35
+140% +$1.03K ﹤0.01% 1808
2024
Q2 		$660 Buy
25
+20
+400% +$569 ﹤0.01% 1863
2024
Q1 		$162 Buy
+5
New +$182 ﹤0.01% 1855

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Rothschild Investment LLC's IMVT Position: Q2 2026 in Review

Rothschild Investment LLC increased its Immunovant (IMVT) stake by 0.92% in Q2 2026, buying an estimated $30 and bringing the position to 110 shares worth $4.24K. The position accounts for ﹤0.01% of the portfolio, ranked #2384.

Rothschild Investment LLC first reported a position in IMVT in Q1 2024 and has held it in 10 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Rothschild Investment LLC held 110 shares of Immunovant worth $4.24K as of Q2 2026.
  • Rothschild Investment LLC bought 1 Immunovant share in Q2 2026, an estimated $30.
  • Immunovant made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2384 holding.
  • Rothschild Investment LLC first reported a position in Immunovant in Q1 2024 and has held it in 10 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.